215 related articles for article (PubMed ID: 36934940)
1. Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective.
Kock A; Glanville HC; Law AC; Stanton T; Carter LJ; Taylor JC
Sci Total Environ; 2023 Jun; 878():162939. PubMed ID: 36934940
[TBL] [Abstract][Full Text] [Related]
2. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
3. Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - Current state of knowledge.
Świacka K; Maculewicz J; Kowalska D; Caban M; Smolarz K; Świeżak J
J Hazard Mater; 2022 Feb; 424(Pt A):127350. PubMed ID: 34607031
[TBL] [Abstract][Full Text] [Related]
4. Emerging contaminants in the aquatic environment: phytoplankton structure in the presence of sulfamethoxazole and diclofenac.
Duarte JAP; Ribeiro AKN; de Carvalho P; Bortolini JC; Ostroski IC
Environ Sci Pollut Res Int; 2023 Apr; 30(16):46604-46617. PubMed ID: 36719587
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of phytoplankton to the increasing presence of active pharmaceutical ingredients (APIs) in the aquatic environment: A review.
Chia MA; Lorenzi AS; Ameh I; Dauda S; Cordeiro-Araújo MK; Agee JT; Okpanachi IY; Adesalu AT
Aquat Toxicol; 2021 May; 234():105809. PubMed ID: 33780670
[TBL] [Abstract][Full Text] [Related]
6. Chemical, biological, and ecotoxicological assessment of pesticides and persistent organic pollutants in the Bahlui River, Romania.
Neamtu M; Ciumasu IM; Costica N; Costica M; Bobu M; Nicoara MN; Catrinescu C; van Slooten KB; De Alencastro LF
Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S76-85. PubMed ID: 19229579
[TBL] [Abstract][Full Text] [Related]
7. Diatom mediated heavy metal remediation: A review.
Kiran Marella T; Saxena A; Tiwari A
Bioresour Technol; 2020 Jun; 305():123068. PubMed ID: 32156552
[TBL] [Abstract][Full Text] [Related]
8. Levels and effects of antidepressant drugs to aquatic organisms.
Moreira DG; Aires A; de Lourdes Pereira M; Oliveira M
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Jun; 256():109322. PubMed ID: 35272041
[TBL] [Abstract][Full Text] [Related]
9. Ecotoxicity of the lipid-lowering drug bezafibrate on the bioenergetics and lipid metabolism of the diatom Phaeodactylum tricornutum.
Duarte B; Prata D; Matos AR; Cabrita MT; Caçador I; Marques JC; Cabral HN; Reis-Santos P; Fonseca VF
Sci Total Environ; 2019 Feb; 650(Pt 2):2085-2094. PubMed ID: 30290350
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna.
Fabbri E
Ann N Y Acad Sci; 2015 Mar; 1340():20-8. PubMed ID: 25557669
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
Mezzelani M; Gorbi S; Regoli F
Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
[TBL] [Abstract][Full Text] [Related]
12. The transportation, transformation and (bio)accumulation of pharmaceuticals in the terrestrial ecosystem.
Zhang C; Barron L; Sturzenbaum S
Sci Total Environ; 2021 Aug; 781():146684. PubMed ID: 33794458
[TBL] [Abstract][Full Text] [Related]
13. Emerging investigator series: towards a framework for establishing the impacts of pharmaceuticals in wastewater irrigation systems on agro-ecosystems and human health.
Carter LJ; Chefetz B; Abdeen Z; Boxall ABA
Environ Sci Process Impacts; 2019 Apr; 21(4):605-622. PubMed ID: 30932118
[TBL] [Abstract][Full Text] [Related]
14. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.
Arnold KE; Brown AR; Ankley GT; Sumpter JP
Philos Trans R Soc Lond B Biol Sci; 2014 Nov; 369(1656):. PubMed ID: 25405959
[TBL] [Abstract][Full Text] [Related]
15. Determination of the pharmaceuticals-nano/microplastics in aquatic systems by analytical and instrumental methods.
Pashaei R; Dzingelevičienė R; Abbasi S; Szultka-Młyńska M; Buszewski B
Environ Monit Assess; 2022 Jan; 194(2):93. PubMed ID: 35028740
[TBL] [Abstract][Full Text] [Related]
16. The ecotoxicological effects of microplastics on aquatic food web, from primary producer to human: A review.
Wang W; Gao H; Jin S; Li R; Na G
Ecotoxicol Environ Saf; 2019 May; 173():110-117. PubMed ID: 30771654
[TBL] [Abstract][Full Text] [Related]
17. The Biological Effects of Pharmaceuticals in the Marine Environment.
Mezzelani M; Regoli F
Ann Rev Mar Sci; 2022 Jan; 14():105-128. PubMed ID: 34425054
[TBL] [Abstract][Full Text] [Related]
18. Ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems: A global assessment.
Camargo JA; Alonso A
Environ Int; 2006 Aug; 32(6):831-49. PubMed ID: 16781774
[TBL] [Abstract][Full Text] [Related]
19. Enantioselectivity in ecotoxicity of pharmaceuticals, illicit drugs, and industrial persistent pollutants in aquatic and terrestrial environments: A review.
Pérez-Pereira A; Carrola JS; Tiritan ME; Ribeiro C
Sci Total Environ; 2024 Feb; 912():169573. PubMed ID: 38151122
[TBL] [Abstract][Full Text] [Related]
20. Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.
Grzesiuk M; Spijkerman E; Lachmann SC; Wacker A
Ecotoxicol Environ Saf; 2018 Jul; 156():271-278. PubMed ID: 29554612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
